JP2010535790A5 - - Google Patents

Download PDF

Info

Publication number
JP2010535790A5
JP2010535790A5 JP2010520238A JP2010520238A JP2010535790A5 JP 2010535790 A5 JP2010535790 A5 JP 2010535790A5 JP 2010520238 A JP2010520238 A JP 2010520238A JP 2010520238 A JP2010520238 A JP 2010520238A JP 2010535790 A5 JP2010535790 A5 JP 2010535790A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
composition according
serotonin reuptake
selective serotonin
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010520238A
Other languages
English (en)
Japanese (ja)
Other versions
JP5460594B2 (ja
JP2010535790A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/072066 external-priority patent/WO2009020897A1/en
Publication of JP2010535790A publication Critical patent/JP2010535790A/ja
Publication of JP2010535790A5 publication Critical patent/JP2010535790A5/ja
Application granted granted Critical
Publication of JP5460594B2 publication Critical patent/JP5460594B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010520238A 2007-08-03 2008-08-04 ドーパミン受容体リガンドを含有する医薬組成物およびドーパミン受容体リガンドを用いる処置方法 Active JP5460594B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US95369407P 2007-08-03 2007-08-03
US60/953,694 2007-08-03
PCT/US2008/072066 WO2009020897A1 (en) 2007-08-03 2008-08-04 Pharmaceutical compositions containing dopamine receptor ligands and methods of treatment using dopamine recptor ligands

Publications (3)

Publication Number Publication Date
JP2010535790A JP2010535790A (ja) 2010-11-25
JP2010535790A5 true JP2010535790A5 (enExample) 2011-09-22
JP5460594B2 JP5460594B2 (ja) 2014-04-02

Family

ID=40338740

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010520238A Active JP5460594B2 (ja) 2007-08-03 2008-08-04 ドーパミン受容体リガンドを含有する医薬組成物およびドーパミン受容体リガンドを用いる処置方法

Country Status (20)

Country Link
US (3) US20090036468A1 (enExample)
EP (1) EP2185155B1 (enExample)
JP (1) JP5460594B2 (enExample)
KR (1) KR101612563B1 (enExample)
CN (1) CN101815519B (enExample)
AU (1) AU2008283989B2 (enExample)
CA (1) CA2695519A1 (enExample)
CY (1) CY1119828T1 (enExample)
DK (1) DK2185155T3 (enExample)
EA (1) EA018064B1 (enExample)
ES (1) ES2653852T3 (enExample)
HR (1) HRP20171908T1 (enExample)
HU (1) HUE036004T2 (enExample)
LT (1) LT2185155T (enExample)
MY (1) MY157192A (enExample)
NO (1) NO2185155T3 (enExample)
PL (1) PL2185155T3 (enExample)
PT (1) PT2185155T (enExample)
SI (1) SI2185155T1 (enExample)
WO (1) WO2009020897A1 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI2317852T1 (sl) 2008-07-16 2015-04-30 Richter Gedeon Nyrt. Farmacevtske formulacije, ki vsebujejo ligande dopaminskega receptorja
US20110117214A1 (en) * 2009-11-16 2011-05-19 Auspex Pharmaceuticals, Inc. Cyclohexyl urea modulators of d2 receptors and/or d3 receptors
JP5860457B2 (ja) 2010-06-18 2016-02-16 アルトス・セラピューティクス・リミテッド・ライアビリティ・カンパニーAltos Therapeutics,Llc D2アンタゴニスト、その合成方法および使用方法
US8912197B2 (en) 2012-08-20 2014-12-16 Forest Laboratories Holdings Ltd. Crystalline form of carbamoyl-cyclohexane derivatives
US11274087B2 (en) 2016-07-08 2022-03-15 Richter Gedeon Nyrt. Industrial process for the preparation of cariprazine
HUP1700253A1 (hu) * 2017-06-13 2019-01-28 Richter Gedeon Nyrt Szilárd orális gyógyszerkészítmények
GB2571696B (en) 2017-10-09 2020-05-27 Compass Pathways Ltd Large scale method for the preparation of Psilocybin and formulations of Psilocybin so produced
US12459965B2 (en) 2017-10-09 2025-11-04 Compass Pathfinder Limited Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use
US11547707B2 (en) 2019-04-10 2023-01-10 Richter Gedeon Nyrt. Carbamoyl cyclohexane derivatives for treating autism spectrum disorder
HU231500B1 (hu) * 2019-04-10 2024-04-28 Richter Gedeon Nyrt Karbamoil-ciklohexán származékok autizmus spektrum betegség kezelésére
WO2020212951A1 (en) 2019-04-17 2020-10-22 Compass Pathfinder Limited Methods for treating anxiety disorders, headache disorders, and eating disorders with psilocybin
EP4422629A4 (en) * 2021-10-28 2025-09-03 Richter Gedeon Nyrt TREATMENT OF MAJOR DEPRESSIVE DISORDER
JP2025500844A (ja) * 2021-12-13 2025-01-15 コンパス パスファインダー リミテッド 治療抵抗性うつ病の治療に使用するためのサイロシビン及び補助的セロトニン再取り込み阻害剤
CA3244202A1 (en) * 2022-03-17 2023-09-21 Mapi Pharma Ltd DEPOSIT SYSTEMS INCLUDING CARIPRAZINE OR SALTS THEREOF

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8814057D0 (en) * 1988-06-14 1988-07-20 Lundbeck & Co As H New enantiomers & their isolation
ZA977967B (en) * 1996-09-23 1999-03-04 Lilly Co Eli Combination therapy for treatment of psychoses
US6960577B2 (en) * 1998-05-22 2005-11-01 Eli Lilly And Company Combination therapy for treatment of refractory depression
US6556540B1 (en) * 1998-05-29 2003-04-29 Paradyne Corporation System and method for non-intrusive measurement of service quality in a communications network
SK287140B6 (sk) * 1999-10-25 2010-01-07 H. Lundbeck A/S Spôsob prípravy citalopramu a medziprodukt na jeho výrobu
UA77650C2 (en) * 1999-12-06 2007-01-15 Lundbeck & Co As H Use of serotonin reuptake inhibitor in combination with deramcyclane
US20040198809A1 (en) * 2001-05-01 2004-10-07 Connie Sanchez Use of enantiomeric pure escitalopram
WO2003086393A1 (en) * 2002-04-12 2003-10-23 Sepracor, Inc. 3-aza- and 1,4-diaza-bicyclo[4.3.0]nonanes, and methods of use thereof
DE60312874T2 (de) * 2002-06-20 2008-01-17 H. Lundbeck A/S Kombinationstherapie mit verwendung eines serotonin-wiederaufnahmehemmers
HU227534B1 (en) * 2003-08-04 2011-08-29 Richter Gedeon Nyrt (thio)carbamoyl-cyclohexane derivatives, process for producing them and pharmaceutical compositions containing them
EA200600531A1 (ru) * 2003-09-04 2006-08-25 Х. Лундбекк А/С Сочетание ингибитора обратного захвата серотонина и локсапина
HUP0500170A3 (en) * 2005-02-03 2007-11-28 Richter Gedeon Nyrt Piperazine derivatives, process for producing them and pharmaceutical compositions containing them
TW200812993A (en) * 2006-05-02 2008-03-16 Lundbeck & Co As H New uses of escitalopram
HU230748B1 (hu) * 2007-05-11 2018-02-28 Richter Gedeon Nyrt Új piperazin só és előállítási eljárása

Similar Documents

Publication Publication Date Title
JP2010535790A5 (enExample)
JP2012521428A5 (enExample)
US9988390B2 (en) Pyrimidone derivatives and their use in the treatment, amelioration or prevention of a viral disease
JP2010527983A5 (enExample)
JP2010527985A5 (enExample)
CA2969557A1 (en) Sulfide alkyl and pyridyl reverse sulfonamide compounds for hbv treatment
JP4751567B2 (ja) 新規アミド誘導体およびその医薬としての用途
JP2012521429A5 (enExample)
JP2010527984A5 (enExample)
JP2015523339A5 (enExample)
JP2015524457A (ja) ジヒドロキシピリミジン炭酸誘導体及びウイルス性疾患の治療、改善又は予防における使用
JP2008001718A5 (enExample)
WO2006096435A1 (en) Pharmaceutical compositions for the treatment and/or prevention of depression
JP2016518305A5 (enExample)
JP2010509356A5 (enExample)
JP2015509535A5 (enExample)
JP2005529926A5 (enExample)
JP2011518811A5 (enExample)
JP2002508364A5 (enExample)
JP2016508145A5 (enExample)
RU2012108423A (ru) Ацилгуанидиновые производные с азотсодержащим циклом
JP2020111571A5 (enExample)
JP2008525400A5 (enExample)
JP2011524898A5 (enExample)
JPWO2022145408A5 (enExample)